137 related articles for article (PubMed ID: 18187487)
1. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
Thasni KA; Rakesh S; Rojini G; Ratheeshkumar T; Srinivas G; Priya S
Ann Oncol; 2008 Apr; 19(4):696-705. PubMed ID: 18187487
[TBL] [Abstract][Full Text] [Related]
2. Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Srinivas G; Annab LA; Gopinath G; Banerji A; Srinivas P
Mol Carcinog; 2004 Jan; 39(1):15-25. PubMed ID: 14694444
[TBL] [Abstract][Full Text] [Related]
3. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
K A T; T R; G R; K C S; Nair RS; G S; Banerji A; Somasundaram V; Srinivas P
Mol Carcinog; 2013 May; 52(5):392-403. PubMed ID: 22290577
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo.
Sinha S; Pal K; Elkhanany A; Dutta S; Cao Y; Mondal G; Iyer S; Somasundaram V; Couch FJ; Shridhar V; Bhattacharya R; Mukhopadhyay D; Srinivas P
Int J Cancer; 2013 Mar; 132(5):1201-12. PubMed ID: 22806981
[TBL] [Abstract][Full Text] [Related]
5. Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status.
Thasni KA; Rojini G; Rakesh SN; Ratheeshkumar T; Babu MS; Srinivas G; Banerji A; Srinivas P
Eur J Pharmacol; 2008 Jul; 588(2-3):158-64. PubMed ID: 18514188
[TBL] [Abstract][Full Text] [Related]
6. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.
Liu X; Cai W; Niu M; Chong Y; Liu H; Hu W; Wang D; Gao S; Shi Q; Hu J; Zhou X; Yu R
J Neurooncol; 2015 Feb; 121(3):469-77. PubMed ID: 25528634
[TBL] [Abstract][Full Text] [Related]
8. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
10. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
Chock KL; Allison JM; Shimizu Y; ElShamy WM
Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.
Kawiak A; Domachowska A; Jaworska A; Lojkowska E
Sci Rep; 2017 Mar; 7():43781. PubMed ID: 28287102
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
15. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
17. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
[TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells.
Sagar S; Esau L; Moosa B; Khashab NM; Bajic VB; Kaur M
Anticancer Agents Med Chem; 2014 Jan; 14(1):170-80. PubMed ID: 24164046
[TBL] [Abstract][Full Text] [Related]
20. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells.
Joo MK; Park JJ; Kim SH; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Int J Oncol; 2015; 46(6):2380-8. PubMed ID: 25815436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
